Clinical Trial Update: A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating Lebrikizumab (MILR1444A) in adults with asthma inadequately controlled on inhaled corticosteroids has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Lebrikizumab (MILR1444A)

Snippet

Sponsor: Genentech, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED